Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ann Wilson

Podiatrist Warrenton, MO Doctor of Podiatric Medicine

NPI 1902911829 CMS profile 531608

18800 Schnucks Dr Ste B, Warrenton, MO 63383

Open in the dashboard

General payments

$1,789

112 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ann Wilson of Warrenton, MO is reported in the CMS Open Payments database as having received $1,789 across 112 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 64th percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $120 6
2024 General $208 9
2023 General $402 24
2022 General $201 11
2021 General $161 10
2020 General $208 12
2019 General $489 40

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ann Wilson
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to Ann Wilson were reported at $120. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year Ann Wilson Podiatrist median Middle half National median
2019 $489 $196 $72–$601 $163
2020 $208 $118 $38–$335 $114
2021 $161 $169 $57–$573 $132
2022 $201 $220 $74–$782 $149
2023 $402 $208 $71–$635 $160
2024 $208 $237 $87–$681 $164
2025 $120 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Organogenesis Inc. $1,238 81 payments
  2. Smith+Nephew, Inc. $221 15 payments
  3. Kerecis Limited $118 6 payments
  4. KCI USA, Inc $60 1 payment
  5. Medtronic, Inc. $35 1 payment
  6. Bioventus LLC $28 1 payment
  7. ETS Wound Care LLC $23 3 payments
  8. Zimvie Inc. $20 1 payment
  9. Integra LifeSciences Corporation $17 1 payment
  10. Tactile Systems Technology Inc $17 1 payment
  11. Other $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,789 112 payments
Products named General payments · program years 2019–2025
  1. Puraply $677 48 payments
  2. Apligraf Wound Care $228 19 payments
  3. Santyl $174 12 payments
  4. REGRANEX $142 7 payments
  5. Puraply Antimicrobial $138 2 payments
  6. Oasis $114 5 payments
  7. Kerecis Omega3 SurgiClose $94 4 payments
  8. Kerecis Omega3 Marigen $87 3 payments
  9. Apligraf Wound Care $65 7 payments
  10. SNAP $60 1 payment
  11. Other $772 42 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

837

Median for Podiatry: 160

Drug cost

$7,812

Median for Podiatry: $2,368

Branded share of claims

8.1%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Doxycycline Monohydrate Generic 85 $1,663
Mupirocin Generic 164 $1,228
Ketoconazole Generic 84 $1,192
Terbinafine Hcl Generic 78 $894
Cephalexin Generic 110 $584
Gabapentin Generic 43 $502
Doxycycline Hyclate Generic 48 $414
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 43 $319
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 25 $223
Cefadroxil Generic 33 $209

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$70,458

Medicare's payments for the services billed

Medicare patients

531

Average age 76

Services billed

2,389

278 women, 253 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Diabetes 49%
Chronic kidney disease 41%
Ischemic heart disease 35%
Heart failure 34%
Atrial fibrillation 31%
Depression 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

112 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record